Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
European Journal of Medicinal Chemistry|January 9, 2017
Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's diseaseJakub Jeřábek, Elisa Uliassi, Laura Guidotti, et al.
Chemmedchem|February 17, 2018
Development of a Focused Library of Triazole-Linked Privileged-Structure-Based Conjugates Leading to the Discovery of Novel Phenotypic Hits against Protozoan Parasitic InfectionsElisa Uliassi, Lorna Piazzi, Federica Belluti, et al.
ACS Chemical Neuroscience|May 23, 2023
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer's DiseaseMelissa Guardigni, Letizia Pruccoli, Alan Santini, et al.
Journal of Medicinal Chemistry|September 27, 2014
Multitarget drug design strategy: quinone-tacrine hybrids designed to block amyloid-β aggregation and to exert anticholinesterase and antioxidant effectsEugenie Nepovimova, Elisa Uliassi, Jan Korabecny, et al.
Chemmedchem|January 22, 2019
Discovery of Sustainable Drugs for Neglected Tropical Diseases: Cashew Nut Shell Liquid (CNSL)-Based Hybrids Target Mitochondrial Function and ATP Production in Trypanosoma bruceiMichela Cerone, Elisa Uliassi, Federica Prati, et al.
ACS Chemical Neuroscience|April 14, 2021
Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's DiseaseLukas Gorecki, Elisa Uliassi, Manuela Bartolini, et al.
RSC Medicinal Chemistry|August 6, 2021
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid propertiesGiselle de Andrade Ramos, Andressa Souza de Oliveira, Manuela Bartolini, et al.
European Journal of Medicinal Chemistry|October 15, 2017
Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activityElisa Uliassi, Giulia Fiorani, R Luise Krauth-Siegel, et al.
ACS Chemical Neuroscience|July 22, 2022
Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral SclerosisClaudia Albertini, Alessandra Salerno, Silvia Atzeni, et al.
European Journal of Medicinal Chemistry|March 10, 2019
Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's diseaseKatarina Chalupova, Jan Korabecny, Manuela Bartolini, et al.
Pageof 5